ABPI position on biosimilar medicines

Updated: 02/06/2015 To support its members, the ABPI has updated its position paper on biosimilar medicines which cover areas where action is needed by regulators, HTA agencies, NHS commissioners and NHS healthcare professionals who prescribe or dispense biosimilar medicines.